USP Quality Review

No. 62, Issued 05/98

In This Issue:

National Efforts Culminate in Council Recommendations

Background

USP/FDA Panel Recommends Improved and Uncrowded Injection Labels
An Act of Congress

NCC MERP: Coordinating and Finalizing Efforts at a National Level

For Regulators and Standards-setters
Implementing NCC MERP Criteria for Safer Labels and Anticipating Future Collaborative Endeavors

To report a medication error or to receive further information, call the USP Medication Errors Reporting Program at 800-23-ERROR (800-233-7767). Online reporting is also available.